Provided By PR Newswire
Last update: Feb 23, 2023
NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and its board of directors concerning the proposed acquisition of the company by MEI Pharma, Inc. (NASDAQ: MEIP). Infinity Pharmaceutical stockholders are expected to own 42% of the combined company. The all-stock transaction is expected to close in mid-2023.
Read more at prnewswire.comNASDAQ:MEIP (5/13/2025, 8:00:01 PM)
2.09
0 (0%)
Find more stocks in the Stock Screener